Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Clinical trial NCT03785964 · COMPLETED

Trial details

NCT number: NCT03785964
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Desmoid Tumor Aggressive Fibromatosis

Start date: 2019-04-17
Primary completion: 2022-04-07
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.